Adverum Biotechnologies Presents Long-term Data through March 10, 2021 from the OPTIC Trial …,

(Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced new long-term …, (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced new long-term …, Read More

Scroll to Top